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Abstract
Background: For the first time, we aimed to introduce a model for prediction of placenta accreta spectrum (PAS),
using existing sonography indices.
Methods: Women with a history of Cesarean sections were included. Participants were categorized “high risk” for
PAS if the placenta was previa or low-lying.
Sonography indices including abnormal placental lacuna, loss of clear zone, bladder wall interruption, myometrial
thinning, placental bulging, exophytic mass, utero-vesical hypervascularity, subplacental hypervascularity, existence
of bridging vessels, and lacunar flow, were registered.
To investigate simultaneous effects of 15 variables on PAS, Minimax Concave Penalty (MCP) was used.
Results: Among 259 participants, 74 (28.5%) were high risk and 43 individuals had PASs.
All sonography indices were higher among patient with PAS (p < 0.001) in the high risk group.
Our model showed that utero-vesical hypervascularity, bladder interruption and new lacunae have significant
contribution in PAS. Optimal cut off point was p = 0.51 in ROC analysis. Probability of PAS for women with lacunae
was between 96 and 100% and probability of PAS for women without lacunae was between 0 to 7%, therefore
accuracy of the proposed model was equal to 100%.
Conclusions: Using the introduced model based on three factors of abnormal lacuna structures (grades 2 and 3),
bladder wall interruption and utero-vesical vascularity, 100% of all cases of PASs are diagnosable. If supported by
future studies our model eliminates the need for other imaging assessments for diagnosis of invasive placentation
among high risk women with previous history of Cesarean sections.
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Background
Invasive placentation or placenta accreta spectrum
(PAS) refers to a spectrum of disorders in which the pla-
centa attaches in a pathological manner to the myome-
trium [1]. In developed countries PAS remains to be the
most common cause for Cesarean hysterectomy [2], on
the other hand the most important risk factor for in-
creased PAS rates are increased Cesarean sections [2].
The incidence of the condition has been estimated to
have increased from 1 in every 2500 pregnancies since
the 1990s [3] to one in every 500 to 600 pregnancies [4].
According to the degree of trophoblastic invasion
through the myometrium three variants can be recog-
nized for PAS, which include 75% as PAS, 18% as
increta, and 7% as percreta [3].
Placenta accreta (used to define all three conditions) is
associated with multiple complications. Among these
complications include: internal organ damage,
hemorrhage, respiratory distress, thromboembolic
events, infections, coagulopathies, genitourinary compli-
cations and finally multi-organ failure and death [5, 6].
Prenatal diagnosis of placenta accreta has been shown
to decrease mortality and morbidity associated with the
condition, as it allows planned intervention [7]. Diagno-
sis of the condition is done through imaging modalities
including MRI and ultrasonography (US), however de-
finitive diagnosis of the condition is based on patho-
logical evaluation after hysterectomy [8, 9]. US remains
to be the first line diagnostic modality among patients
suspected of placenta accreta due to factors like easiness
of use, easy access, the minor invasive nature and the
lower expense compared to MRI [9].
Multiple indices have been introduced in US which
are used for the diagnosis of accreta, however the same
signs have shown varying accuracy for the diagnosis of
accreta in different studies. This has been attributed to
factors like the subjective nature and operator depend-
ency of sonography, different study design and eventual
diagnosis of the accreta [10, 11].
Recently, the European Working Group on Abnor-
mally Invasive Placenta (EW-AIP) released a report on
existing sonography parameters for the diagnosis of
accreta in order to improve international comparisons
and to unify definition of accreta in literature and to
provide standard definitions for US indices [12].
To date, multiple studies have compared sonography
and MRI for the diagnosis of accreta [8, 10]. Moreover,
some studies have also focused on each sonography
index and have separately defined accuracy of each son-
ography index for the diagnosis of accreta [9, 13, 14].
These studies lack homogeneity and differ in their re-
ports, mainly due to the lack of a unified definition.
In this study, using the definitions provided by the
EW-AIP, we aimed to define a standard model for the
prediction of PAS among women with a history of
Cesarean section, using existing sonography indices. We
further compared each index regarding their agreement
and prediction power for PAS based on the gold stand-
ard diagnostic modality, separately.
Methods
Study setting and patient selection
This is a prospective cross-sectional study performed in
Hafez Hospital affiliated to Shiraz University of Medical
Sciences, Shiraz, Iran. In this study all women with a his-
tory of at least one previous Cesarean section, during
March 20th 2016 to February 19th 2017, were consid-
ered for inclusion in the study. Among these, all women
in their second and third trimester of pregnancy who re-
ferred to the perinatology ward of the medical care cen-
ter for the evaluation of site of placenta and placental
adhesion, were included in the study. All women who
referred during their first trimester were asked to refer
during their second trimester as well.
Individuals without a history of Cesarean sections, and
those who did not refer for their follow-ups were ex-
cluded from the study. Figure 1 shows the flow diagram
related to patients’ recruitment.
Study protocol
Every individual underwent systematic two-dimensional
grey-scale US imaging (GE Voluson R 730, GE medical
systems, Zipf, Austria). Initially, site of placenta was eval-
uated using abdominal transducers. In cases of suspicion
of low lying placenta or placenta previa, trans-vaginal
sonography was done, during which patients had an
empty bladder and the distance between placental edge
and the internal cervical orifice was measured. The term
“placenta previa” was used when the placental edge over-
laped or was within 2 cm of the internal cervical orifice
in late pregnancy, and the term “low-lying” was used if
the placental edge was located further than 2 cm but
within 3.5 cm from the internal cervical orifice. In these
cases, trans-vaginal US were repeated, during which the
bladder was filled with 300 ml of liquid for better evalu-
ation of the uterine serosa-bladder interfaces. Accord-
ingly, participants were categorized in the “high risk”
group for PAS if the placenta was previa or low-lying.
For placentas that contained abnormal vessels or lacu-
nae structures, color Doppler sonography was done in
order to map the vascularization of the intraplacental
and uterine serosa-bladder interface and to measure the
velocity flow of the inter-lacunae turbulant.
Patients classified as high risk for PAS were further re-
evaluated just before planned delivery.
In each of the US and Doppler examinations the
following parameters were examined: 1) presence of
multiple placental lacunae. These irregularly shaped
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hypoechoic vascular spaces larger than 1*1 cm in size
within the placental parenchyma, may give the pla-
centa a “Swiss cheese” appearance, often containing
turbulent flow that is visible on gray scale imaging.
According to Finberg’s grading scale for lacunae
[15], the structures were categorized as followed:
grade 1+ for one to three lacunae structures, which
are usually small, grade 2+ for four to six lacunae
structures, which are typically larger, and grade 3+
which shows diffuse lacunae throughout the pla-
centa, 2) losing or irregularity in the echolucent area
between the placenta and the myometrium (clear
space), 3) thinning or interruption of the hypere-
choic interface between the uterine serosa and blad-
der wall (bladder line), 4) presence of an exophytic
mass caused by intrusion of the placental tissue into
the bladder, 5) sub-placental hypervascularity, 6)
utero-vesical vascularity, 7) bridging vessels that ex-
tended from the placenta into the bladder wall via
the myometrium. In case of existence of feeding ves-
sels into the lacunae, velocity of blood flow within
the lacunae structures was also measured.
Sonography imaging was done mainly during the third
trimester, except in women who presented with history
of rupture of membranes or vaginal bleeding or any
emergency condition that would place that individual at
risk of termination of pregnancy, during which US was
done at any gestational age. In cases with multiple US
examinations, the last scan before delivery was consid-
ered for study.
All known and suspected cases of PAS were admitted
to the high risk pregnancy department at 33–34 weeks
of gestation and a formal multidisciplinary management
and treatment program was initiated for them by a
trained team [16].
Surgical assessment
According to our protocol, surgery was done with a sur-
gical oncology team, general surgery team, and a urology
team stationed at the high risk center, in which blood
products were easily accessible and facilities such as
postoperative ICU care was available. Moreover, a neo-
natal care department and a neonatal team were also
present at the center. Surgery was initiated with
Fig. 1 Flow diagram showing patient recruitment
Boroomand fard et al. BMC Pregnancy and Childbirth          (2020) 20:111 Page 3 of 10
adequate hydration and among patients who were sus-
pected of adhesion, according to preoperative sonog-
raphy, a fundal incision was made. With a fundal
hysterotomy the child was delivered. The umbilical cord
was closed at the nearest site to the placenta. If the pa-
tient was hemodynamically stable, without any effort to
separate the placenta, a quick evaluation was done in 1–
2 min. If the placenta had no invasion to the outer wall
of the uterus and there was no bulging or bridging ves-
sels existing between the uterus and the intestines or the
bladder, moreover the patient remained
hemodynamically stable, if the placenta had completely
separated during this time, a standard typical Cesarean
section would be performed. If the placenta was sepa-
rated from all regions and was only attached in a few
centimeters from the middle, if the surgery team would
determine that by ligation of vessels or even removal of
a few centimeters of the uterus, they are able to separate
the placenta and save the uterus, then this approach was
done. In cases in which during after birth, the patient
was hemodynamically unstable, hemodynamic resuscita-
tion was initiated and hysterectomy was done. Moreover,
in cases where, the patient was hemodynamically stable,
however the placenta had invaded the outer wall of the
uterus or in cases where dilated or bridging vessels were
seen between the uterus and the bladder or intestines,
after birth and clamping of umbilical vessels, hysterec-
tomy was done.
There was no attempt to remove the placenta
manually.
For the purpose of this study, invasive placentation
was suspected based on clinical assessment of abnormal
adherence and evidence of gross placental invasion at
time of surgery, after which histopathological study of
the excised uterus confirmed the diagnosis of PAS.
All participant had declined conservative treatment
(preserving the uterus with the placenta left in situ) or
didn’t fulfill criteria for this treatment approach.
Pathology evaluation
The uterus and the attached placenta were first weighed
and measured. The external surface of the uterus, espe-
cially the anterior and lower segments, was evaluated for
any hematoma, ruptured and bulging areas. Areas suspi-
cious of percreta were inked and then the uterus was
bivalved using a knife. The specimens were fixed in 10%
neutral-buffered formalin overnight. Serial bread-loaf
sections of the uterus were checked for areas of increta/
percreta. Multiple sections were taken from suspicious
areas of accreta and myometrial invasion. Moreover, two
sections from the cervix or lower uterine segment (in
supra-cervical hysterectomy) were taken to represent
placenta previa. Four full wall thickness sections of non-
attached areas of placental disc and sections of
membrane and umbilical cord were taken for evaluation
of placental abnormality. All sections were stained with
hematoxylin and eosin and were then evaluated by an
expert pathologist.
The absence of decidua between the placental villi and
myometrium was considered placenta accreta, deeper in-
vasion into the myometrium was considered increta, and
complete invasion through the uterine was considered
percreta [17].
Definition of variables
Location of placenta in sonography was classified as: an-
terior high, fundal region posterior high, lateral high, an-
terior low lying, posterior low lying, lateral low, anterior
previa, and posterior previa.
Data on age, number of Cesarean sections, gestational
age at which diagnosis of PAS was considered, gesta-
tional age of delivery, gestational age of first Cesarean
section, risk factors including: previous rupture of
uterus, dilation and curettage, other operations, myo-
mectomy, and sonography indices including abnormal
placental lacuna, loss of clear zone, bladder wall inter-
ruption, myometrial thinning, placental bulging, exophy-
tic mass, utero-vesical hypervascularity, subplacental
hypervascularity, existence of bridging vessels, lacunar
flow, and final diagnosis were registered for each patient.
High pressure in placental lacuna was considered as
blood velocity higher than 15 cm/s [18].
In order to increase coherency and objectivity of study,
all definitions of sonography indices used in the study,
were done according to the unified definitions proposed
by the EW-AIP 2016 [12]. Moreover, to remove any
inter-observer bias, all sonography evaluations were
done by a single radiologist who was blinded to the clas-
sification of patients (high risk or low risk groups).
In our study we considered grade 2 and grade 3 lacuna
according to the the EW-AIP description as “new
lacuna”.
Statistical analysis
All univariate analysis was done using the SPSS® soft-
ware for windows®, version 18, (SPSS Inc., Chicago,
IL, USA). Initially individuals were classified as high
risk and low risk groups (based on the existence of
low lying placenta or placenta previa), after which
they were categorized as PAS and non-PAS (based on
pathology reports) and compared accordingly. For
comparison of qualitative data the Chi-square test
and the Fisher’s exact test and for comparison of
normally distributed quantitative data, the
independent-test was used. Furthermore, for compari-
son of quantitative data without a normal distribution
the Mann-Whitney test was used.
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The Kappa test was used to evaluate the overlap and
agreement of each sonography index with the gold
standard modality, for the diagnosis of PAS.
The receiver operator characteristic (ROC) curve ana-
lysis was used to define sensitivity and specificity of each
sonography index compared to the gold standard diag-
nostic modality for the diagnosis of PAS. A cut-off point
was also defined based on lacunar flow among individ-
uals with lacunar structures to estimate the occurrence
of PAS. The Youden index was used to define the opti-
mal cut-off point based on lacunar flow for diagnosing
PAS. The Youden index considers a point on the ROC
curve optimum which has the maximum sensitivity and
specificity [19].
Due to the nature of PAS rates among pregnant indi-
viduals, and due to the relatively small sample size and
large number of variables, using traditional logistic re-
gression was not appropriate in this setting. To investi-
gate simultaneous effects of 15 variables on PAS,
Minimax Concave Penalty (MCP) was used. Like other
penalized models, degree of shrinkage in MCP is regu-
lated by the tuning parameter which is a positive con-
stant and estimates using the cross validation technique.
Classification accuracy of the proposed model was inves-
tigated by obtained probability of PAS for each case and
optimal cut-off point was determined using the ROC
curve analysis. Statistical analysis was performed using
SPSS 18.0 and ncvreg package in R 3.3.1 software.
In the agreement analysis and the regression model
abnormal lacuna structures were re-defined into a differ-
ent variable as new lacuna. New lacuna was categorized
into two categories as followed: those with grade 0 and 1
were considered as no lacuna and those with grades 2
and 3 as positive for new lacuna.
A p-value of less than 0.05 was considered statistically
significant.
Results
During the study period, a total of 3 patients did not
have a history of Cesarean sections and were referred
due to thinning of the myometrium and 3 patients did
not refer for their follow-up visits. In total, 2 individuals
had emergency interventions before 28 weeks. This in-
cluded women who presented with vaginal bleeding or
premature rupture of membrane or any emergency con-
dition that would place that individual at risk of termin-
ation of pregnancy. These individuals were excluded
from the study.
Table one shows baseline and clinical characteristics
in both high risk and low risk groups. A total of 259 in-
dividuals entered the study, among which 74 (28.5%) pa-
tients were classified as high risk. From the total 74 high
risk patients, 31 of them had spontaneous separation of
placenta in the operating room and only underwent
Cesarean section. A total of 43 individuals in this group,
had Cesarean hysterectomy due to a high suspicion of
PAS in the operating room, which was further confirmed
with pathology evaluation.
Individuals in the high risk group were older (31.43 ±
4.48 vs. 33.19 ± 4.25; p = 0.004), had a lower number of
Cesarean sections (1.61 ± 0.77 vs. 1.93 ± 0.76; p = 0.003),
a lower gestational age of diagnosis (32.01 ± 5.35 vs.
34.80 ± 3.46; p < 0.001), and a lower gestational age at
time of delivery (34.14 ± 4.97 vs. 38.30 ± 1.87; p < 0.001)
(Table 1).
Among individuals who had PAS, higher rates of ab-
normal placental lacuna was detected (p < 0.001), fur-
thermore higher lacunar flow was also detected (16.59 ±
8.63 vs. 1.02 ± 3.69, p < 0.001).
All other sonography indices evaluated among high
risk patients, as expected, were higher among patient
with PAS compared to those without PAS (Table 2).
When comparing each sonography index, existence of
utero-vesical hypervascularity (kappa: 0.916, sensitivity:
90.3%, specificity: 100%), bridging vessels (kappa: 0.891,
sensitivity: 100%, specificity: 90.7%), bladder interruption
(kappa: 0.838, sensitivity: 86%, specificity: 100%), and
subplacental hypervascularity (kappa: 0.808, sensitivity:
85.3%, specificity: 95%) showed the highest agreement
for the diagnosis of PAS when cross compared to the
gold standard diagnosis (Table 3).
Using the ROC curve analysis we determined the
optimum cut-off point based on flow in lacuna struc-
tures for the diagnosis of PAS. Accordingly, a cut-off of
11.5 cm/s was defined, which had a sensitivity of 79%
and specificity of 93% and an accuracy of 90% for the
diagnosis of PAS (Fig. 2).
In the regression analysis, the tuning parameter was
estimated as 0.011 using the 5-fold cross validation tech-
nique (Fig. 3).
Imposing the tuning parameter on the MCP logistic
regression, lead to the elimination of 12 out of 15 vari-
ables from the model. The proposed model revealed that
utero-vesical hypervascularity, bladder interruption and
new lacunae have significant contribution in PAS. In
addition probability of PAS for each case was calculated
using MCP logistic model as followed:
pi ¼ e
−10:4þ5:78Bladder interuptionþ7:84utero−vesicular vascularityþ5:97new:lacunae
1þ e−10:4þ5:78Bladder interuptionþ7:84utero−vesicular vascularityþ5:97new:lacunae
Optimal cut off point was determined as p = 0.51 in
the ROC analysis. Probability of PAS for women with la-
cunae was between 96 and 100% and probability of lacu-
nae for women without PAS was between 0 to 7%,
therefore accuracy of the proposed model was equal to
100%.
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Table 2 Sonography related indices among individuals classified as high risk*
Variable Sub group PAS (n = 43) No PAS (n = 31) P-value
Abnormal placental lacuna No 0 170 (78.7) < 0.001
Grade 1 4 (9.3) 28 (13)
Grade 2 12 (27.9) 17 (7.9)
Grade 3 27 (62.8) 1 (0.5)
Lacunar flow 16.59 ± 8.63 1.02 ± 3.69 < 0.001
Bladder interruption No 6 (14) 31 (100) < 0.001
Yes 37 (86) 0
Myometrial thinning No 15 (34.9) 30 (96.8) < 0.001
Yes 28 (65.1) 1 (3.2)
Placental bulging No 25 (58.1) 31 (100) < 0.001
Yes 18 (41.9) 0
Exophytic mass No 25 (58.1) 31 (100) < 0.001
Yes 18 (41.9) 0
Vesicular hypervascularity No 0 28 (90.3) < 0.001
Yes 42 (100) 3 (9.7)
Subplacental hypervascularity No 5 (11.6) 29 (93.5) < 0.001
Yes 38 (88.4) 2 (6.5)
Bridging vessels No 4 (9.3) 31 (100) < 0.001
Yes 39 (90.7) 0
Loss of clear zone No 20 (46.5) 30 (96.8) < 0.001
Yes 23 (53.5) 1 (3.2)
PAS: placenta accreta spectrum
*All plus-minus values are means and standard deviations, unless stated otherwise. Sonography indices were only evaluated in patients who were considered high
risk (except for evaluation of lacunar structures and subsequently, lacunar blood flow)
Table 1 Baseline and clinical characteristics of the study population*
Variable Sub group Low risk (n = 185) High risk (n = 74)† p-value
Age - yrs 31.43 ± 4.48 33.19 ± 4.25 0.004
Site of placenta - no. (%) Anterior high 142 (76.3) 0 < 0.001
Fundal posterior high 34 (18.3) 0
Lateral high 10 (5.4) 0
Anterior low lying 0 9 (12.2)
Posterior low lying 0 7 (9.5)
Lateral low lying 0 2 (2.7)
Anterior previa 0 18 (24.3)
Posterior previa 0 6 (8.1)
Number of Caesarean sections - median (interquartile range) 2 (1, 2) 1 (1, 2) 0.003
Gestational age at diagnosis - wks 34.80 ± 3.46 32.01 ± 5.35 < 0.001
Gestational age at time of delivery - wks 38.30 ± 1.87 34.14 ± 4.97 < 0.001
Time of first Caesarean section - wks 4.90 ± 2.70 4.96 ± 2.87 0.88
Risk factors - no. (%)‡ No 171 (92.4) 67 (90.5) 0.614
Yes 14 (7.6) 7 (9.5)
*All plus-minus values are means and standard deviations unless stated otherwise
†High risk individuals were those who had low lying placenta or placenta previa
‡Risk factors included: rupture of uterus, dilation and curettage, myomectomy and other operations
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Discussion
We aimed to introduce a model for the diagnosis of PAS
based on sonography indexes in a group of high risk
women for invasive placentation, furthermore we also
compared each sonography index with the gold standard
diagnosis of PAS and obtained the agreement and diag-
nostic value of each index, separately. We found that for
the diagnosis of PAS all previously known sonography
indices including: existence of abnormal placental la-
cuna, bladder interruption, myometrial thinning, placen-
tal bulging, existence of exophytic mass, utero-vesical
vascularity, subplacental vascularity, bridging vessels,
and loss of clear zone are significantly higher among
those with PAS. Furthermore, we found that among all
these indices utero-vesical vascularity, bridging vessels,
bladder interruption, and subplacental vascularity have
the highest agreement with gold standard diagnosis. As
the main goal of our study we defined a model based on
existing sonography indices to define the chances of hav-
ing PAS which had a 100% accuracy. In our model the
three indices of utero-vesical hypervascularity, bladder
interruption and new lacunae were predictive of PAS. In
addition, existence of abnormal lacuna structures alone
had a predicting power of 96 to 100% for PAS. We also
found that using lacuna flow rate at a cut-off of 11.5 cm/
s can predict PAS with an accuracy of 90%.
Similar to that reported in our study, Comstock et al.
[20] reported that visualization of placental lacuna to be
the most reliable diagnostic sign [sensitivity: 93% and
positive predictive value (PPV): 93%] for the diagnosis of
accreta among women with a history of Cesarean section
in their third trimester (for most of their patients) of
pregnancy. Although their study included limited num-
ber of sonography criteria, their report was in concord-
ance with our findings as we found that existence of
lacuna structures in our final model could predict
accreta by a precision 96 and 100% during the third tri-
mester of pregnancy. Their findings also showed that ex-
istence of lacunae structures during 15–40 weeks of
gestational age compared to 15–20 weeks of gestational
age had a better sensitivity and PPV. Aside to the larger
population size and the different analysis performed be-
tween the two studies, this study showed that existence
of lacuna may be more reliable as gestational age in-
creases and considering that in our study all patients
were in their third trimester of pregnancy and most re-
cent radiological images were considered for evaluation,
this may be among the reasons why we had a signifi-
cantly higher recorded accuracy for the lacunae index in
detecting accreta. A narrative review by D’Antonio et al.
[1] in 2016, reported that among 23 studies that evalu-
ated placental lacuna diagnostic efficiency, a pooled sen-
sitivity of 77%, specificity of 95%, PLR of 4.5%, NLR of
0.29%, and diagnostic odds ratio of 24.32% was reported
for the diagnosis of invasive placentation.
Table 3 Agreement between sonography indexes and gold standard measurement for diagnosis of placenta accreta spectrum*
Variables Accuracy Kappa Sensitivity Specificity P-value
Utero-vesical hypervascularity 95.9 (88.6–99.1) 0.92 90.3 (74.3–98) 100 (91.8–100) < 0.001
Bridging vessels 94.6 (86.7–98.5) 0.89 100 (88.8–100) 90.7 (77.9–97.4) < 0.001
Bladder interruption 91.9 (83.2–97.0) 0.84 86.0 (72.1–94.7) 100 (88.8–100) < 0.001
Subplacental hypervascularity 90.5 (81.5–96.1) 0.81 85.3 (68.9–95.1) 95.0 (83.1–99.4) < 0.001
New lacuna† 91.5 (87.4–94.6) 0.73 98.0 (95.0–99.5) 68.4 (54.8–80.1) < 0.001
Myometrial thinning 78.4 (67.3–87.1) 0.58 96.8 (83.3–99.9) 65.1 (49.1–79.0) < 0.001
Loss of clear zone 71.6 (60.0–81.5) 0.46 53.5 (37.7–68.8) 96.8 (8.3–99.9) < 0.001
Placental bulging 66.2 (54.3–76.8) 0.38 100 (88.8–100) 41.9 (27.0–57.9) < 0.001
Exophytic mass 66.2 (54.3–76.8) 0.38 100 (88.8–100) 41.9 (27.0–57.9) < 0.001
*Except for new lacuna, all other indexes were evaluated in individuals considered high risk
†New lacuna was considered as grade 2 and 3 in sonography evaluation
Fig. 2 Receiver operator characteristic (ROC) curve analysis for the
diagnosis of accreta based on lacuna flow rates
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D’Antonio [1] reported a pooled sensitivity of 49%,
specificity of 99.75%, PLR of 30.56%, NLR of 0.51%, and
diagnostic odds ratio of 93.7% for bladder interruption
for the diagnosis of invasive placentation. We found this
index to be significant in our final model for the predic-
tion of PAS, furthermore this index had a high agree-
ment score with that of the gold standard, which shows
that in most occasions this index is measured in accord-
ance with that of the gold standard modality. Regarding
bladder interruption, Cumstock et al. [20] found a sensi-
tivity of 20% and PPV of 75% for the detection of
accreta. Bladder interruption was also seen among all
patients with either accreta or increta in a small older
series by Hoffman-Tretin and colleagues [21].
Utero-vascular hypervascularity was another factor
that presented as significant in our model. In a recent
study by Maged et al. [22] a total of 100 individuals with
a history of Cesarean section were evaluated and com-
pared in two groups, those with accreta and those with-
out accreta. Similar to our study, they found all
sonography indices in their study (loss of clear zone, la-
cunae, utero-vesical hypervascularity, and subplacental
hypervascularity) to be significantly higher in the accreta
group. They found utero-vesical hypervascularity to have
a sensitivity of 47.6%, specificity of 94.5%, PPV of 93.7,
and 51.4%, and accuracy of 65% for diagnosis of accreta.
They also found lacunae structures to have a sensitivity
of 93.6%, specificity of 62.1%, PPV of 80, 85% of NPV,
and accuracy of 82%.
In a meta-analysis published in 2013 by Meng et al.
[8], the diagnostic value of US and MRI were com-
pared with regards to detecting placenta accreta. They
found that among a total of 13 studies that compared
the two diagnostic modalities, US had a sensitivity of
83% and specificity of 95% and MRI had a sensitivity of
82% and specificity of 88% for the diagnosis of accreta.
They concluded that US and MRI do not differ regard-
ing diagnostic value.
Although other diagnostic modalities such as MRI are
done to confirm diagnosis of placenta accreta in poster-
ior and some cases of lateral placental site implantation
[1], our findings show that using the introduced model,
almost 100% of all cases of PASs are diagnosed. If sup-
ported by future studies our model can significantly aid
in the diagnosis of invasive placentation among high risk
(considered those with a low lying placenta or previa)
women with previous history of Cesarean sections.
To the best of the authors’ knowledge, this is the first
model to predict PAS among women with previous
Cesarean section with a probability of almost 100%, and
among the most comprehensive studies that has in-
cluded all sonography indices for prediction of PAS. If
further supported by future studies, the model can be
used to diagnose the existence of PAS among women
with a history of Cesarean sections and low lying pla-
centa or placenta previa using only US parameters.
This study was not without limitation. First is the na-
ture of US, as it is operator dependent, all measurements
need to be done by an expert in sonography. However,
for the first time, we did use standardized definitions
provided by the EW-AIP in our study in order to allevi-
ate this issue [12]. Overall, due to the nature of our
study and the rarity of PAS, similar to previous litera-
ture, we did not have a large sample of individuals with
PAS, and accordingly our final model needs to be veri-
fied by future literature. However, we did use advanced
statistical modeling to eliminate this issue. Among limi-
tations of the study could be that, due to the high costs
Fig. 3 This shows the tuning parameter which was estimated as 0.011 using the 5-fold cross validation technique
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of pathology evaluation of the placenta, those who had
spontaneous extraction of placenta during Cesarean sec-
tion did not undergo pathology evaluation for focal
accreta.
Among the limitation of the current report is that
some forms of PAS including a less aggressive form of
placenta accreta may be managed with conservative sur-
gery, on the other hand more aggressive forms require a
more radical approach. As our primary outcome was
considered to be the existence of PAS we did not stratify
patients based on the degree of PAS (placenta accreta/
increta versus placenta percreta) and thus our model
can only be used for the diagnosis of PAS and does not
allow a classification of severity of the condition, which
represent one of the main issues in the current manage-
ment of PAS.
Another issue relates to the statistical modeling used
in our study, MCP is among penalized methods, and al-
though penalized methods were initially developed for
high-dimensional conditions and data, in conditions
where variables may be correlated, even when less than
10 variables exist, this method is an excellent choice.
Furthermore, in the presence of multicollinearity, trad-
itional variable selection techniques such as stepwise,
forward and backward methods can lead to misleading
results as they are aggressive methods. In short, penal-
ized regression presence among the best choices even in
low dimensional data [23]. In MCP, we include all exist-
ing variables (potential risk factors meaning all the vari-
ables in the current study) in the final model as in other
penalized models, and perform simultaneous estimation
and variable selection. Nature of the penalty function,
which is added in the maximum likelihood of the model,
forces some coefficients to shrink to zero and eliminates
redundant variables from the model.
As recent findings have indicated that perhaps scar
from previous Cesarean section may be among the
primary causes of accreta [24], in here we only in-
cluded individuals with a history of Cesarean sections
and our final model is only applicable in these
individuals.
Considering that at the time of our study the new
FIGO guidelines did not exist for the definition of
PAS, future studies would benefit from the use of
more recent definition proposed by the “FIGO Safe
Motherhood and Newborn Health Committee” and to
focus on models that aside to the diagnosis of PAS,
would provide a means for stratification of severity of
PAS as well.
Conclusions
In conclusion, we found that using the introduced model
based on three factors of abnormal lacuna structures
(grades 2 and 3), bladder wall interruption and utero-
vesical vascularity, 100% of all cases of PASs are diagnos-
able among women with previous Cesarean sections.
Abbreviation
MCP: Minimax Concave Penalty; PAS: Placenta accreta spectrum; PPV: Positive
predictive value; ROC: Receiver operator characteristic; US: Ultrasonography
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